- Home
- AUST vs LGVN Comparison
AUST vs LGVN Comparison
Compare AUST & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUST
- LGVN
- Stock Information
- Founded
- AUST 2020
- LGVN 2014
- Country
- AUST Canada
- LGVN United States
- Employees
- AUST N/A
- LGVN N/A
- Industry
- AUST
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- AUST
- LGVN Health Care
- Exchange
- AUST Nasdaq
- LGVN Nasdaq
- Market Cap
- AUST 39.0M
- LGVN 31.2M
- IPO Year
- AUST 2022
- LGVN 2021
- Fundamental
- Price
- AUST $1.78
- LGVN $2.02
- Analyst Decision
- AUST
- LGVN Strong Buy
- Analyst Count
- AUST 0
- LGVN 2
- Target Price
- AUST N/A
- LGVN $8.00
- AVG Volume (30 Days)
- AUST 436.2K
- LGVN 701.3K
- Earning Date
- AUST 11-06-2024
- LGVN 11-12-2024
- Dividend Yield
- AUST N/A
- LGVN N/A
- EPS Growth
- AUST N/A
- LGVN N/A
- EPS
- AUST N/A
- LGVN N/A
- Revenue
- AUST N/A
- LGVN $1,852,000.00
- Revenue This Year
- AUST N/A
- LGVN $161.78
- Revenue Next Year
- AUST N/A
- LGVN $8.73
- P/E Ratio
- AUST N/A
- LGVN N/A
- Revenue Growth
- AUST N/A
- LGVN 141.46
- 52 Week Low
- AUST $0.62
- LGVN $0.77
- 52 Week High
- AUST $3.19
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- AUST 41.88
- LGVN 49.76
- Support Level
- AUST $2.23
- LGVN $1.93
- Resistance Level
- AUST $2.42
- LGVN $2.31
- Average True Range (ATR)
- AUST 0.35
- LGVN 0.17
- MACD
- AUST -0.14
- LGVN 0.00
- Stochastic Oscillator
- AUST 1.05
- LGVN 34.30
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.